August 22, 2010 (FinancialWire, The Small Cap News Leader) (Go to http://www.financialwire.net/?s=chnchn for more articles like these.) — Recent “China In-Focus” news includes Renhuang Pharmaceuticals, Inc. (AMEX: CBP), World Wide Relics (OTCBB: WRLC), Wowjoint Holdings Ltd. (NASDAQ: BWOW), Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM), New Energy Systems Group (AMEX: NEWN) and others:

Renhuang Receives Package Design Patent — Renhuang Pharmaceuticals, Inc. (AMEX: CBP), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, said that the State Intellectual Property Office of China of the People's Republic of China recently granted the company patent protection for the product packaging design for its Compound Honeysuckle Granules … (continued at http://www.financialwire.net/2010/08/20/renhuang-receives-patent/).

China PharmaHub, Chengdu Yongkon Ink Pact — China PharmaHub Corp., which recently merged with World Wide Relics (OTCBB: WRLC), said it has signed a cooperation agreement with Chengdu Yongkon Pharmacy Co. Ltd … (continued at http://www.financialwire.net/2010/08/19/pharmahub-chengdu-pact/).

Wowjoint Inks China Railway Contract — Wowjoint Holdings Ltd. (NASDAQ: BWOW), a provider of heavy duty lifting and carrying machinery used in large-scale infrastructure projects, said it has signed a $4.3 million sales contract with China Railway Group … (continued at http://www.financialwire.net/2010/08/17/infrastructure-public-utilities-wowjoint/).

Go to http://www.financialwire.net/?s=chnchn for more articles like these.

=========

Equity research on any public company is available through the Shareholders Research Alliance (go to http://www.investrend.com/synd0004 for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html).  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[ssryrsyr] [nwscycrvw] [chnnfcsqqxx] [ftrdnwswnd]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.